167 related articles for article (PubMed ID: 8548767)
21. [Study on telomerase activity and its clinical value in human non small cell lung cancer].
Chen Q; He J; Yi H
Hunan Yi Ke Da Xue Xue Bao; 2001 Jun; 26(3):221-2. PubMed ID: 12536686
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues.
Yousef GM; Stephan C; Scorilas A; Ellatif MA; Jung K; Kristiansen G; Jung M; Polymeris ME; Diamandis EP
Prostate; 2003 Sep; 56(4):287-92. PubMed ID: 12858357
[TBL] [Abstract][Full Text] [Related]
23. Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer.
Zhang L; Shi J; Feng J; Klocker H; Lee C; Zhang J
Prostate Cancer Prostatic Dis; 2004; 7(4):327-32. PubMed ID: 15356679
[TBL] [Abstract][Full Text] [Related]
24. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
Leav I; McNeal JE; Ho SM; Jiang Z
Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556
[TBL] [Abstract][Full Text] [Related]
25. Telomerase activity in disseminated prostate cancer cells.
Pfitzenmaier J; Ellis WJ; Arfman EW; Hawley S; McLaughlin PO; Lange PH; Vessella RL
BJU Int; 2006 Jun; 97(6):1309-13. PubMed ID: 16686730
[TBL] [Abstract][Full Text] [Related]
26. Tyrosine protein kinase activity of human hyperplastic prostate and carcinoma cell lines PC3 and DU145.
Durocher Y; Chapdelaine A; Chevalier S
Cancer Res; 1989 Sep; 49(17):4818-23. PubMed ID: 2474374
[TBL] [Abstract][Full Text] [Related]
27. Dipeptidylpeptidase IV activities are elevated in prostate cancers and adjacent benign hyperplastic glands.
Wilson MJ; Ruhland AR; Quast BJ; Reddy PK; Ewing SL; Sinha AA
J Androl; 2000; 21(2):220-6. PubMed ID: 10714816
[TBL] [Abstract][Full Text] [Related]
28. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
Luo J; Zha S; Gage WR; Dunn TA; Hicks JL; Bennett CJ; Ewing CM; Platz EA; Ferdinandusse S; Wanders RJ; Trent JM; Isaacs WB; De Marzo AM
Cancer Res; 2002 Apr; 62(8):2220-6. PubMed ID: 11956072
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
30. Human telomerase reverse transcriptase expression correlates with vascular endothelial growth factor-promoted tumor cell proliferation in prostate cancer.
Tang J; Wang Z; Li X; Li J; Shi H
Artif Cells Blood Substit Immobil Biotechnol; 2008; 36(2):83-93. PubMed ID: 18437586
[TBL] [Abstract][Full Text] [Related]
31. Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
Patel MM; Parekh LJ; Jha FP; Sainger RN; Patel JB; Patel DD; Shah PM; Patel PS
Head Neck; 2002 Dec; 24(12):1060-7. PubMed ID: 12454944
[TBL] [Abstract][Full Text] [Related]
32. mRNA expression of the five membrane-type matrix metalloproteinases MT1-MT5 in human prostatic cell lines and their down-regulation in human malignant prostatic tissue.
Jung M; Römer A; Keyszer G; Lein M; Kristiansen G; Schnorr D; Loening SA; Jung K
Prostate; 2003 May; 55(2):89-98. PubMed ID: 12661033
[TBL] [Abstract][Full Text] [Related]
33. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
Wu K; Lund M; Bang K; Thestrup-Pedersen K
Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
[TBL] [Abstract][Full Text] [Related]
34. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors.
de Kok JB; Verhaegh GW; Roelofs RW; Hessels D; Kiemeney LA; Aalders TW; Swinkels DW; Schalken JA
Cancer Res; 2002 May; 62(9):2695-8. PubMed ID: 11980670
[TBL] [Abstract][Full Text] [Related]
35. Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer.
Suh CI; Shanafelt T; May DJ; Shroyer KR; Bobak JB; Crawford ED; Miller GJ; Markham N; Glode LM
Mol Cell Probes; 2000 Aug; 14(4):211-7. PubMed ID: 10970725
[TBL] [Abstract][Full Text] [Related]
36. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
37. [Detection of telomerase activity in salivary tumor and its significance].
Chen LJ; Huang JH; Li Z
Hunan Yi Ke Da Xue Xue Bao; 2002 Jun; 27(3):282-4. PubMed ID: 12575319
[TBL] [Abstract][Full Text] [Related]
38. Telomerase activity and alterations in telomere length in human brain tumors.
Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N
Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755
[TBL] [Abstract][Full Text] [Related]
39. [Telomerase activity in liver cancer and the adjacent tissue].
Fu J; Zhang W; Jin S
Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):434-6. PubMed ID: 10920937
[TBL] [Abstract][Full Text] [Related]
40. Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN).
Koeneman KS; Pan CX; Jin JK; Pyle JM; Flanigan RC; Shankey TV; Diaz MO
J Urol; 1998 Oct; 160(4):1533-9. PubMed ID: 9751408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
